Cystic Fibrosis Foundation - Click here for homepage
Stay Informed  |  Volunteer  |  Clinical Trials

In This Section

Quick Links

Find a Chapter

Get Assistance

Get Assistance - Cox Boys
We are here to help people with CF get the insurance coverage they need. Hear how the Foundation helped the Cox family.

Join us on Facebook!  Facebook 
Follow us on Twitter!   Twitter
Follow us on Instagram!  Instagram 
Add us to your circle in Google+!

Google+ 

Subscribe to our channel on YouTube!  YouTube  


 

 

Print  

CF Foundation’s Drug Pipeline Recognized by Pharmaceutical Approvals Monthly

December 19, 2007

The December issue of Pharmaceutical Approvals Monthly, a leading publication for the biotech industry, highlights the success of the CF Foundation’s drug discovery and development pipeline.

The outlook for CF drug development is "a very different story than even five years ago," Robert Beall, Ph.D., president and CEO of the CF Foundation, says in the story. "We're really starting to see the return now on the investments. We've never had a pipeline like this…we're leveraging our investment."

The story notes that the CF Foundation invests more than any other disease foundation in the U.S. and is a model for venture philanthropy in orphan diseases. Since 1998, the foundation has invested more than $300 million in early stage development to entice firms to look at CF drugs.

Today, more than 15 therapies specifically indicated for CF patients are in development or in clinical trials, and another 15 previously used for other indications are also testing in CF patients, the article notes. And, as a marker of a maturing pipeline, Gilead Sciences recently submitted a New Drug Application to the U.S. Food and Drug Administration for marketing approval of an investigational therapy in development for people with cystic fibrosis.

Read the full story from Pharmaceutical Approvals Monthly.

 

GFC Holiday Promo

The Cystic Fibrosis Foundation is an accredited charity of the Better Business Bureau.